|
US663780A
(en)
*
|
1898-09-09 |
1900-12-11 |
Wheeler & Wilson Mfg Co |
Trimming attachment for sewing-machines.
|
|
US4302204A
(en)
|
1979-07-02 |
1981-11-24 |
The Board Of Trustees Of Leland Stanford Junior University |
Transfer and detection of nucleic acids
|
|
US4358535A
(en)
|
1980-12-08 |
1982-11-09 |
Board Of Regents Of The University Of Washington |
Specific DNA probes in diagnostic microbiology
|
|
FI63596C
(fi)
|
1981-10-16 |
1983-07-11 |
Orion Yhtymae Oy |
Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
|
|
US4994373A
(en)
|
1983-01-27 |
1991-02-19 |
Enzo Biochem, Inc. |
Method and structures employing chemically-labelled polynucleotide probes
|
|
AR240698A1
(es)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
US6060237A
(en)
|
1985-02-26 |
2000-05-09 |
Biostar, Inc. |
Devices and methods for optical detection of nucleic acid hybridization
|
|
US4965188A
(en)
|
1986-08-22 |
1990-10-23 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US5112460A
(en)
|
1986-10-21 |
1992-05-12 |
Northeastern University |
High performance microcapillary gel electrophoresis
|
|
EP0306228B1
(en)
|
1987-09-04 |
1999-11-17 |
Beecham Group Plc |
Substituted thiazolidinedione derivatives
|
|
US5595883A
(en)
|
1990-06-01 |
1997-01-21 |
E. R. Squibb & Sons, Inc. |
Method of diagnosing alzheimer's disease by measuring acetylcholinesterase activity in ocular fluid
|
|
US5171750A
(en)
|
1991-09-26 |
1992-12-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
Substituted phenserines as specific inhibitors of acetylcholinesterase
|
|
TW263504B
(enExample)
|
1991-10-03 |
1995-11-21 |
Pfizer |
|
|
US5326770A
(en)
|
1992-07-17 |
1994-07-05 |
The Du Pont Merck Pharmaceutical Company |
Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals
|
|
IL106877A
(en)
|
1992-09-10 |
1998-03-10 |
Lilly Co Eli |
Rhodanine derivatives for use as medicaments for the treatment of alzheimer's disease
|
|
FI951701L
(fi)
|
1992-10-13 |
1995-04-10 |
Univ Duke |
Menetelmät Alzheimerin taudin tunnistamiseksi
|
|
TWI238064B
(en)
|
1995-06-20 |
2005-08-21 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
|
ES2100129B1
(es)
|
1995-10-11 |
1998-02-16 |
Medichem Sa |
Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
|
|
JPH09176162A
(ja)
|
1995-12-22 |
1997-07-08 |
Toubishi Yakuhin Kogyo Kk |
チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
|
|
US6128587A
(en)
|
1997-01-14 |
2000-10-03 |
The Regents Of The University Of California |
Method and apparatus using Bayesian subfamily identification for sequence analysis
|
|
US5904824A
(en)
|
1997-03-07 |
1999-05-18 |
Beckman Instruments, Inc. |
Microfluidic electrophoresis device
|
|
JP2001514663A
(ja)
*
|
1997-03-12 |
2001-09-11 |
エスモンド，ロバート ダブリュー． |
アルツハイマー病を処置または予防するための方法
|
|
EP0869122B1
(en)
|
1997-03-31 |
2002-12-04 |
Korea Research Institute Of Chemical Technology |
Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof
|
|
EP1047423B1
(en)
|
1997-11-19 |
2006-05-10 |
Takeda Pharmaceutical Company Limited |
Novel apoptosis inhibitors
|
|
US6964868B1
(en)
|
1998-01-28 |
2005-11-15 |
Nuvelo, Inc. |
Human genes and gene expression products II
|
|
US20040058873A1
(en)
*
|
1998-03-12 |
2004-03-25 |
Esmond Robert W. |
Method for treating or preventing Alzheimer's disease
|
|
AU4187499A
(en)
|
1998-05-14 |
1999-11-29 |
Chiron Corporation |
Human genes and gene expression products v
|
|
EP1088104B1
(en)
|
1998-06-16 |
2006-02-08 |
Nova Molecular, Inc. |
Methods for treating a neurological disease by determining bche genotype
|
|
US6368797B1
(en)
|
1998-10-01 |
2002-04-09 |
Variagenics, Inc. |
Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant BPIIb allele
|
|
DK1129216T3
(da)
|
1998-11-10 |
2005-01-17 |
Genset Sa |
Fremgangsmåder, software og apparater til identificering af genomiske regioner, der huser et gen associeret med en påviselig egenskab
|
|
US6191154B1
(en)
|
1998-11-27 |
2001-02-20 |
Case Western Reserve University |
Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
|
|
CN1078616C
(zh)
*
|
1998-12-16 |
2002-01-30 |
中国科学院上海生命科学研究中心 |
一种检测样品中是否存在老年痴呆病基因的方法和试剂盒
|
|
JP2000273040A
(ja)
*
|
1999-01-19 |
2000-10-03 |
Sankyo Co Ltd |
トログリタゾンを含有するアポトーシス抑制剤
|
|
US6401043B1
(en)
|
1999-04-26 |
2002-06-04 |
Variagenics, Inc. |
Variance scanning method for identifying gene sequence variances
|
|
CA2371391A1
(en)
|
1999-04-29 |
2000-11-09 |
City Of Hope |
Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
|
|
US6573049B1
(en)
|
1999-07-26 |
2003-06-03 |
Nuvelo, Inc. |
Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease
|
|
DE19936719A1
(de)
|
1999-08-06 |
2001-02-15 |
Gruenenthal Gmbh |
Substituierte 1,5-Dihydropyrrol-2-on-Derivate
|
|
US6559188B1
(en)
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
|
AR030920A1
(es)
|
1999-11-16 |
2003-09-03 |
Smithkline Beecham Plc |
Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
|
|
US6680322B2
(en)
|
1999-12-02 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
US6532467B1
(en)
|
2000-04-10 |
2003-03-11 |
Sas Institute Inc. |
Method for selecting node variables in a binary decision tree structure
|
|
US6432985B2
(en)
|
2000-04-25 |
2002-08-13 |
Hoffmann-La Roche Inc. |
Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonists
|
|
JP2004531459A
(ja)
|
2000-10-11 |
2004-10-14 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロールマネージメント用スルホキシドおよびビススルホキシド化合物ならびに組成物および関連する使用
|
|
US7304093B2
(en)
|
2000-10-11 |
2007-12-04 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
JP2004532799A
(ja)
|
2000-10-11 |
2004-10-28 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロール管理および関連用途のためのスルフィド化合物およびジスルフィド化合物ならびにそれらを含む組成物
|
|
US20040122091A1
(en)
|
2000-10-11 |
2004-06-24 |
Esperion Therapeutics, Inc. |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
CN1283610C
(zh)
|
2000-10-11 |
2006-11-08 |
埃斯佩里安医疗公司 |
用于控制胆固醇以及相关用途的酮化合物以及组合物
|
|
US6838452B2
(en)
|
2000-11-24 |
2005-01-04 |
Vascular Biogenics Ltd. |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
|
AU2002218461B2
(en)
|
2000-11-24 |
2006-09-07 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
US6495335B2
(en)
|
2000-12-07 |
2002-12-17 |
Mario Chojkier |
Compositions and methods for diagnosing alzheimer's disease
|
|
DE10132725A1
(de)
|
2001-07-05 |
2006-08-03 |
Grünenthal GmbH |
Substituierte γ-Lactonverbindungen
|
|
US6680299B2
(en)
|
2001-07-27 |
2004-01-20 |
Enanta Pharmaceuticals, Inc. |
4'-substituted leucomycins
|
|
US20040204502A1
(en)
|
2001-10-11 |
2004-10-14 |
Dasseux Jean-Louis Henri |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
US20050020694A1
(en)
|
2001-10-11 |
2005-01-27 |
Dasseux Jean-Louis Henri |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
US6828462B2
(en)
|
2001-11-07 |
2004-12-07 |
Merz Pharma Gmbh & Co. Kgaa |
Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
|
|
US7132244B2
(en)
|
2001-11-21 |
2006-11-07 |
Syn X Pharma, Inc. |
Betaine/GABA transport protein biopolymer marker indicative of insulin resistance
|
|
US7052849B2
(en)
|
2001-11-23 |
2006-05-30 |
Syn X Pharma, Inc. |
Protein biopolymer markers predictive of insulin resistance
|
|
US7135297B2
(en)
|
2001-11-23 |
2006-11-14 |
Nanogen Inc. |
Protein biopolymer markers indicative of insulin resistance
|
|
US20030220374A1
(en)
|
2002-01-14 |
2003-11-27 |
Pharmacia Corporation |
Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
|
|
JPWO2004005510A1
(ja)
|
2002-07-05 |
2005-11-04 |
塩野義製薬株式会社 |
新規Ｎｏｇｏ受容体様ポリペプチドおよびそのＤＮＡ
|
|
US20040265849A1
(en)
*
|
2002-11-22 |
2004-12-30 |
Applera Corporation |
Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
|
|
CN1753662A
(zh)
*
|
2002-12-24 |
2006-03-29 |
神经化学（国际）有限公司 |
用于治疗β－淀粉状蛋白相关疾病的治疗制剂
|
|
US20050021236A1
(en)
*
|
2003-02-14 |
2005-01-27 |
Oklahoma Medical Research Foundation And Intergenetics, Inc. |
Statistically identifying an increased risk for disease
|
|
US7141669B2
(en)
|
2003-04-23 |
2006-11-28 |
Pfizer Inc. |
Cannabiniod receptor ligands and uses thereof
|
|
US20050004179A1
(en)
|
2003-05-22 |
2005-01-06 |
Pedersen Ward A. |
Methods and materials for treating, detecting, and reducing the risk of developing Alzheimer's Disease
|
|
US20070203083A1
(en)
|
2003-06-13 |
2007-08-30 |
Mootha Vamsi K |
Methods Of Regulating Metabolism And Mitochondrial Function
|
|
WO2005028426A1
(ja)
|
2003-09-19 |
2005-03-31 |
Chugai Seiyaku Kabushiki Kaisha |
新規４−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのmek阻害剤としての使用
|
|
JP2007526764A
(ja)
|
2004-01-22 |
2007-09-20 |
ジェネッサンス ファーマシューティカルズ，インコーポレイティド |
アルツハイマー病の発症年齢に関連するａｐｏｅ遺伝子マーカー
|
|
TW200538738A
(en)
|
2004-02-20 |
2005-12-01 |
Univ California |
Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
|
|
WO2006054297A2
(en)
|
2004-11-17 |
2006-05-26 |
Compugen Ltd. |
Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
|
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
|
EP1859056A2
(en)
|
2005-01-31 |
2007-11-28 |
Perlegen Sciences, Inc. |
Genetic basis of alzheimer's disease and diagnosis and treatment thereof
|
|
CA2620333A1
(en)
|
2005-08-26 |
2007-03-01 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
EP1940403A2
(en)
|
2005-09-22 |
2008-07-09 |
SB Pharmco Puerto Rico Inc. |
Ppar-gamma agonists for improvement of cognitive function in apoe4 negative patients
|
|
WO2007044522A1
(en)
|
2005-10-05 |
2007-04-19 |
Auburn University |
P62 as a risk determinant for metabolic syndrome
|
|
RU2445957C2
(ru)
|
2006-03-16 |
2012-03-27 |
Метаболик Солюшнз Девелопмент Компани |
Аналоги тиазолидиндиона
|
|
US20080045582A1
(en)
|
2006-05-15 |
2008-02-21 |
Issam Zineh |
ENA-78 Gene Polymorphisms and Protein Concentrations as Diagnostic and Prognostic Tools
|
|
EP2037948B1
(en)
|
2006-05-30 |
2016-04-13 |
Mayo Foundation For Medical Education And Research |
Detecting and treating dementia
|
|
US7651840B2
(en)
|
2006-07-14 |
2010-01-26 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
|
|
CA2663347A1
(en)
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
Ppar mediated modulation of neurogenesis
|
|
US20090042849A1
(en)
|
2006-12-06 |
2009-02-12 |
Yochai Birnbaum |
Phosphorylation of 5-lipoxygenase at ser523 and uses thereof
|
|
US7794937B2
(en)
|
2006-12-22 |
2010-09-14 |
Quest Diagnostics Investments Incorporated |
Cystic fibrosis transmembrane conductance regulator gene mutations
|
|
GB0702537D0
(en)
|
2007-02-12 |
2007-03-21 |
Leuven K U Res & Dev |
Treatment for excessive adiposity
|
|
US20080286876A1
(en)
|
2007-05-14 |
2008-11-20 |
Chissoe Stephanie |
GENES ASSOCIATED WITH ALZHEIMER'S DISEASE - Hltdip
|
|
US8652508B2
(en)
|
2007-05-25 |
2014-02-18 |
Children's Medical Center Corporation |
Dietary formulations and methods for treatment of inflammation and other disorders
|
|
TW200914006A
(en)
|
2007-07-12 |
2009-04-01 |
Takeda Pharmaceutical |
Coated preparation
|
|
US8846315B2
(en)
*
|
2008-08-12 |
2014-09-30 |
Zinfandel Pharmaceuticals, Inc. |
Disease risk factors and methods of use
|
|
NZ710443A
(en)
|
2008-08-12 |
2019-03-29 |
Zinfandel Pharmaceuticals Inc |
Method of identifying disease risk factors
|
|
US20100136584A1
(en)
|
2008-09-22 |
2010-06-03 |
Icb International, Inc. |
Methods for using antibodies and analogs thereof
|
|
WO2010033913A1
(en)
|
2008-09-22 |
2010-03-25 |
Icb International, Inc. |
Antibodies, analogs and uses thereof
|
|
US7888035B2
(en)
|
2008-10-30 |
2011-02-15 |
Caris Mpi, Inc. |
Methods for assessing RNA patterns
|
|
EP3181705A1
(en)
|
2008-11-12 |
2017-06-21 |
Caris Life Sciences Switzerland Holdings GmbH |
Methods and systems of using exosomes for determining phenotypes
|
|
CA2745854A1
(en)
|
2008-12-12 |
2010-06-17 |
Daniel Cravo |
Tetrahydrotriazine compounds for treating diseases associated with ampk activity
|
|
KR101682489B1
(ko)
|
2009-02-02 |
2016-12-05 |
라일라 뉴트라슈티칼스 |
대사성 증후군의 조절을 위한 스파란터스 인디커스 및 가르시니아 망고스타나 유래의 조성물
|
|
US8865648B2
(en)
|
2009-04-23 |
2014-10-21 |
Siemens Healthcare Diagnostics Inc. |
Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
|
|
CA2709621A1
(en)
|
2009-09-11 |
2011-03-11 |
Electrophoretics Limited |
Markers and methods relating to the assessment of alzheimer's disease
|
|
US20110195425A1
(en)
|
2010-02-10 |
2011-08-11 |
Selinfreund Richard H |
Systems and methods for diagnosing parasite infections
|
|
CN103237901B
(zh)
|
2010-03-01 |
2016-08-03 |
卡里斯生命科学瑞士控股有限责任公司 |
用于治疗诊断的生物标志物
|
|
CA2795776A1
(en)
|
2010-04-06 |
2011-10-13 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Circulating biomarkers for disease
|
|
AU2012205798B2
(en)
*
|
2011-01-10 |
2016-02-25 |
Takeda Pharmaceutical Company Limited |
Methods and drug products for treating Alzheimer's disease
|